FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/098621 [Registered on: 08/12/2025] Trial Registered Prospectively
Last Modified On: 07/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Comparison of dexamethasone and ketamine as a supplement to levobupivacaine for pain relieving nerve block technique in lower back surgery. 
Scientific Title of Study   Efficacy of dexamethasone versus ketamine as adjuvant to 0.25 percentage Levobupivacaine in Ultrasound-guided erector spinae plane block in lumbar fusion surgery- A randomized controlled study. 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Debasis Kuanar 
Designation  Consultant 
Affiliation  Kalinga Institute Of Medical Sciences 
Address  Department of Anaesthesiology , 3rd floor , Kalinga Institute Of Medical Sciences , Bhubaneswar.
Kalinga Institute Of Medical Sciences, Bhubaneswar
Khordha
ORISSA
751024
India 
Phone  07381056574  
Fax    
Email  dkuanar1982@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Amit Pradhan 
Designation  Professor 
Affiliation  Kalinga Institute Of Medical Sciences 
Address  Department of Anaesthesiology, 3rd floor , Kalinga Institute Of Medical Sciences, Bhubaneswar

Khordha
ORISSA
751024
India 
Phone  9437191002  
Fax    
Email  amitpdear@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Alisha Mohanty 
Designation  PGT-1 
Affiliation  Kalinga Institute Of Medical Sciences 
Address  Department of Anaesthesiology ,3rd floor , Kalinga Institute Of Medical Sciences, Bhubaneswar

Khordha
ORISSA
751024
India 
Phone  9668215230  
Fax    
Email  am8576@gmail.com  
 
Source of Monetary or Material Support  
Kalinga Institute Of Medical Sciences, Bhubaneswar, Khordha, Odisha, PIN 751024 
 
Primary Sponsor  
Name  DrDebasis Kuanar 
Address  Department of Anaesthesiology 3rd floor Kalinga Institute Of Medical Sciences Bhubaneswar 751024 Odisha India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Debasis Kuanar  Pradyumna Bal Memorial Hospital, Kalinga Institute Of Medical Sciences  Department of Anaesthesiology. 3rd floor , Kalinga Institute Of Medical Sciences, Bhubaneswar
Khordha
ORISSA 
07381056574

dkuanar1982@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Comittee , Kalinga Institute Of Medical Sciences, KIIT deemed to be University, Bhubaneswar-751024  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Addition of Dexamethasone as adjuvant to 0.25 percent of Levobupivacaine in Erector spinae block for lumbar fusion surgery  Group 1: will receive 20 ml of 0.25 percent Levobupivacaine + Dexamethasone 1mg bilaterally in ultrasound guided erector spinae block for a single shot block, as a one time administration before surgery. 
Comparator Agent  Addition of Ketamine as adjuvant to 0.25 percent Levobupivacaine in Erector spinae block in lumbar fusion surgery  Group 2- will receive 20 ml of 0.25 percent Levobupivacaine + Ketamine 50mg bilaterally in ultrasound guided erector spinae block for a single shot block, as a one time administration before surgery. 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1.American Society Of Anaesthesiologists(ASA) physical status I-III.
2.Patients aged more then 30 years undergoing single level lumbar fusion surgery . 
 
ExclusionCriteria 
Details  1.Allergy to study drugs
2.Coagulopathy
3.Local and systemic infections.
4.Patients with cognitive impairment .
5.BMI more than or equal to 30 kg per m²
6.Lumbar spine injury.
7.Significant hepatic and renal function impairment.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the Visual Analog Scale(VAS) pain scores to 0,2,4,8,12,18 and 24 hours post operatively  0,2,4,8,12,18 and 24 hours  
 
Secondary Outcome  
Outcome  TimePoints 
1.Intraoperative- Heart Rate (HR), Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Mean Arterial Pressure (MAP) before incision, 3mins after incision and then every 15 minutes till the end of surgery,
2.Time to first rescue analgesic.
3.Total number of times of requirement of rescue analgesic.
4.Incidence of side effects like respiratory depression, sedation, nausea and vomiting.
 
1.Before incision.
2.3 mins after incision.
3.Every 15 mins after incision. 
 
Target Sample Size   Total Sample Size="68"
Sample Size from India="68" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   18/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

 The erector spinae plane (ESP) block is a safe and effective technique for postoperative analgesia in Lumbar Fusion Surgery.  Dexamethasone, a glucocorticoid acting via C fiber inhibition, or Ketamine which is a NMDA receptor antagonist when added to Levobupivacaine can prolong its analgesic effect.

 Primary objective: To assess postoperative pain scores over 24 hours in patients undergoing lumbar spine fusion surgery who receive either a combination of levobupivacaine and dexamethasone or ketamine. 

Secondary Objective: Intraoperative hemodynamic changes , Time of requirement of first rescue analgesic ,total number of times of requirement of rescue analgesic. and its associated side effects.

 
Close